Accordingly, Perez et al. recently showed that a monoclonal antibody (1H11) specifically targeting a cancer-specific plectin isoform inhibited the plectin activity and caused cell cycle arrest at the G0/G1 checkpoint in the antibody-treated cells [159]. This evidence concerns the gene PLEC and cancer.